Nancy Ryan Gray

Insider Reports History

Location
San Diego, CA
Signature
By: /s/ Andrew Reardon, Attorney-in-Fact For: Nancy Ryan Gray
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nancy Ryan Gray:

Company Role Class Num Shares Value Price $ Report Date Ownership
LIGAND PHARMACEUTICALS INC Director Common Stock 8,094 $1,662,912 $205.45 07 Nov 2025 Direct
LIGAND PHARMACEUTICALS INC Director Non-Qualified Stock Option (right to buy) 0 07 Nov 2025 Direct

Insider Reports Filed by Nancy Ryan Gray

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LGND LIGAND PHARMACEUTICALS INC 07 Nov 2025 6 -$892,827 4 Director 12 Nov 2025, 16:45
LGND LIGAND PHARMACEUTICALS INC 06 Jun 2025 2 $0 4 Director 10 Jun 2025, 19:39
LGND LIGAND PHARMACEUTICALS INC 14 Jun 2024 2 $0 4 Director 18 Jun 2024, 21:26
LGND LIGAND PHARMACEUTICALS INC 09 May 2024 1 -$77,713 4 Director 17 May 2024, 20:00
LGND LIGAND PHARMACEUTICALS INC 09 Jun 2023 2 $0 4 Director 13 Jun 2023, 18:55
LGND LIGAND PHARMACEUTICALS INC 22 Dec 2022 1 $0 4 Director 27 Dec 2022, 17:31
LGND LIGAND PHARMACEUTICALS INC 10 Jun 2022 2 $0 4 Director 13 Jun 2022, 18:46
LGND LIGAND PHARMACEUTICALS INC 04 Jun 2021 2 $0 4 Director 07 Jun 2021, 21:24